JP2010504339A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010504339A5 JP2010504339A5 JP2009529269A JP2009529269A JP2010504339A5 JP 2010504339 A5 JP2010504339 A5 JP 2010504339A5 JP 2009529269 A JP2009529269 A JP 2009529269A JP 2009529269 A JP2009529269 A JP 2009529269A JP 2010504339 A5 JP2010504339 A5 JP 2010504339A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- group
- cell surface
- surface marker
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 23
- 239000002458 cell surface marker Substances 0.000 claims 8
- 241001629511 Litchi Species 0.000 claims 4
- 239000002771 cell marker Substances 0.000 claims 4
- 210000004443 dendritic cell Anatomy 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 3
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 2
- 210000003719 b-lymphocyte Anatomy 0.000 claims 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 210000005087 mononuclear cell Anatomy 0.000 claims 2
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims 1
- 102100036601 Aggrecan core protein Human genes 0.000 claims 1
- 108010067219 Aggrecans Proteins 0.000 claims 1
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 1
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims 1
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 1
- 101150013553 CD40 gene Proteins 0.000 claims 1
- 102100035793 CD83 antigen Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 1
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims 1
- 101000946856 Homo sapiens CD83 antigen Proteins 0.000 claims 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims 1
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims 1
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 108010002352 Interleukin-1 Proteins 0.000 claims 1
- 102000000589 Interleukin-1 Human genes 0.000 claims 1
- 108090000978 Interleukin-4 Proteins 0.000 claims 1
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 claims 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims 1
- 108010069196 Neural Cell Adhesion Molecules Proteins 0.000 claims 1
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims 1
- 102100040120 Prominin-1 Human genes 0.000 claims 1
- 108010026552 Proteome Proteins 0.000 claims 1
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims 1
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84667606P | 2006-09-21 | 2006-09-21 | |
| PCT/US2007/020628 WO2008036421A2 (en) | 2006-09-21 | 2007-09-21 | Reishi-mediated enhancement of human tissue progenitor cell adhesion and differentiation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010504339A JP2010504339A (ja) | 2010-02-12 |
| JP2010504339A5 true JP2010504339A5 (https=) | 2011-11-10 |
Family
ID=39201125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009529269A Pending JP2010504339A (ja) | 2006-09-21 | 2007-09-21 | ヒト組織前駆細胞の接着および分化の、レイシ媒介増強 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20080247989A1 (https=) |
| EP (1) | EP2099465A4 (https=) |
| JP (1) | JP2010504339A (https=) |
| WO (1) | WO2008036421A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7687064B2 (en) | 2001-08-06 | 2010-03-30 | Academia Sinica | Methods and compositions associated with administration of an extract of Ganoderma lucidum |
| US7135183B1 (en) | 2001-08-06 | 2006-11-14 | Academia Sinica | Immuno-modulating antitumor activities of Ganoderma lucidum (Reishi) polysaccharides |
| US8906380B2 (en) * | 2005-10-14 | 2014-12-09 | Academia Sinica | Fungal immunostimulatory compositions |
| US20080214442A1 (en) * | 2006-09-21 | 2008-09-04 | Alice Yu | Anti-Viral Effect of an Extract of Ganoderma Lucidum |
| US7947283B2 (en) | 2007-08-30 | 2011-05-24 | Wyntek Corporation | Compositions and methods for treating psoriasis by Ganoderma lucidum (Reishi) polysaccharides |
| US7785600B2 (en) | 2007-08-30 | 2010-08-31 | Wyntek Corporation | Compositions and methods for treating allergies, auto-immune diseases, and improving skin condition by ganoderma lucidum (reishi) polysaccharides |
| US8071105B2 (en) * | 2008-04-21 | 2011-12-06 | Academia Sinica | Reishi F3 sub fraction polysaccharides and methods of using same |
| BR112012033548A2 (pt) | 2010-06-28 | 2017-06-20 | Stemtech Int Inc | métodos e composições para melhorar a mobilização de células-tronco |
| EP2779834A4 (en) * | 2011-11-18 | 2015-07-08 | Stemtech International Inc | USE OF FO-TI TO IMPROVE MOBILIZATION AND PROLIFERATION OF STEM CELLS |
| US11628190B2 (en) * | 2015-08-28 | 2023-04-18 | University Of South Florida | Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| DE3886986T2 (de) * | 1987-04-28 | 1994-08-11 | Meiji Milk Prod Co Ltd | Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens. |
| EP0941766B1 (en) * | 1998-03-12 | 2006-12-20 | Miltenyi Biotec GmbH | Micro column system for magnetic separation |
| CN1330302C (zh) * | 1999-12-15 | 2007-08-08 | 株式会社氨基厄普化学 | 来源于担子菌培养物的物质、其制造方法及其用途 |
| CN1298740A (zh) * | 2000-04-18 | 2001-06-13 | 邱晓辉 | 一种治疗跌打和风湿病的组合物 |
| US6613754B1 (en) * | 2000-09-22 | 2003-09-02 | National Yang-Ming University | Polysaccharide-based extract from ganoderma, pharmaceutical use thereof, and process for preparing the same |
| JP4132635B2 (ja) * | 2000-10-24 | 2008-08-13 | 株式会社玄米酵素 | 未失活酵素強化組成物 |
| JP4368540B2 (ja) * | 2001-05-16 | 2009-11-18 | 長岡 均 | 骨軟化症予防剤 |
| US20030095981A1 (en) * | 2001-05-30 | 2003-05-22 | Kin-Ping Wong | Compositions containing an active fraction isolated from ganoderma lucidum and methods of use |
| US7135183B1 (en) * | 2001-08-06 | 2006-11-14 | Academia Sinica | Immuno-modulating antitumor activities of Ganoderma lucidum (Reishi) polysaccharides |
| US7687064B2 (en) * | 2001-08-06 | 2010-03-30 | Academia Sinica | Methods and compositions associated with administration of an extract of Ganoderma lucidum |
| JP3984522B2 (ja) * | 2001-09-27 | 2007-10-03 | 日本メナード化粧品株式会社 | マトリックスメタロプロテアーゼ阻害剤 |
| US6464982B1 (en) * | 2001-11-02 | 2002-10-15 | Chinese Herbal Usa, Inc. | Herbal immune system stimulant |
| JP3817223B2 (ja) * | 2002-12-19 | 2006-09-06 | Ｔｄｋ株式会社 | 薄膜磁気ヘッド及びその製造方法 |
| JP2008517100A (ja) * | 2004-10-14 | 2008-05-22 | アカデミア シニカ | ＧａｎｏｄｅｒｍａＬｕｃｉｄｕｍの抽出物の投与に関連した方法及び組成物 |
| US8906380B2 (en) * | 2005-10-14 | 2014-12-09 | Academia Sinica | Fungal immunostimulatory compositions |
-
2007
- 2007-09-21 WO PCT/US2007/020628 patent/WO2008036421A2/en not_active Ceased
- 2007-09-21 EP EP07838767A patent/EP2099465A4/en not_active Withdrawn
- 2007-09-21 US US11/859,738 patent/US20080247989A1/en not_active Abandoned
- 2007-09-21 JP JP2009529269A patent/JP2010504339A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010504339A5 (https=) | ||
| Kawashima | Characterisation of dental pulp stem cells: a new horizon for tissue regeneration? | |
| IL212368A (en) | Compounds that increase the spread of hematopoietic stem cells, in vitro methods to increase the number of stem and progenitor cells, a population of cells containing striated hematopoietic stem cells, preparations containing it, and the use of said cells in drug production. | |
| HRP20230424T1 (hr) | Postupci i pripravci za prirodnoubilačke stanice | |
| MX348491B (es) | Tableta a prueba de manipulacion que proporciona liberacion inmediata de fármaco. | |
| HRP20180266T1 (hr) | Postupak priprave osnovnog medija za kulturu mezenhimnih matičnih stanica, osnovni medij za kulturu mezenhimnih matičnih stanica, te terapijsko sredstvo za stanice koje se uzgaja i diferencira uz njegovu upotrebu | |
| MX348054B (es) | Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco. | |
| NZ591146A (en) | Composition comprising mesenchymal stem cell aggregates wherein the D90 of said aggregates is less than 150 micomills | |
| MX2013000733A (es) | Composiciones de noribogaina. | |
| IN2014DN08862A (https=) | ||
| MY161389A (en) | Method for amplifying nk cells | |
| PH12018500371B1 (en) | Clinical formulations | |
| PL2007429T3 (pl) | Doustna kompozycja o korzystnym działaniu sercowo-naczyniowym, zawierająca berberynę | |
| NZ597193A (en) | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy | |
| JP2011500858A5 (https=) | ||
| BR112013026363A2 (pt) | nanossuspensões de fármaco criodessecadas | |
| WO2007127454A3 (en) | Hepatocyte lineage cells | |
| EA201101332A1 (ru) | Составы | |
| JP2014509319A5 (https=) | ||
| MY188227A (en) | Settable compositions comprising wollastonite and pumice and methods of use | |
| IL221504B (en) | Compositions and methods for targeting type 1 interferon producing cells | |
| PH12013501549A1 (en) | Oral care compositions | |
| PH12013502252B1 (en) | Induction of il-12 using immunotherapy | |
| WO2010121122A3 (en) | Biomechanical induction of hematopoiesis | |
| IL177244A0 (en) | Astaxanthin, esters thereof and compositions containing them, for regulating gene expression, and their use in the manufacture of medicaments |